Aviva Portfolio holdings
Aviva is a British insurer whose roots go back to the Hand in Hand fire and life insurance society, set up in 1696. The group was formed in 2000 as CGNU, when Norwich Union merged with CGU, and shareholders chose the invented name Aviva in 2002, built from the Latin word for alive. It has since grown through deals including the takeover of Friends Life in 2015 and the purchase of Direct Line Group in 2025. Besides selling general and life insurance, it offers savings products and manages money for clients.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Union Pacific
UNP
|
+$24.2M |
| 2 |
UBS Group
UBS
|
+$18.4M |
| 3 |
AGN.PRA
Allergan plc
AGN.PRA
|
+$16.8M |
| 4 |
NextEra Energy
NEE
|
+$15.4M |
| 5 |
Boston Properties
BXP
|
+$14.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$43.2M |
| 2 |
Baxter International
BAX
|
+$19.8M |
| 3 |
GE Aerospace
GE
|
+$18.4M |
| 4 |
IBM
IBM
|
+$15.2M |
| 5 |
ACTAVIS PLC Pfd Conv Ser A (Irl)
ACT.PRA
|
+$14.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.01% |
| 2 | Healthcare | 14.09% |
| 3 | Technology | 13.53% |
| 4 | Industrials | 8.98% |
| 5 | Communication Services | 8.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Apple
AAPL
$5.03T
| $502M | 3.55% |
15,999,112
-177,676
| -1% | -$5.68M |
2013 Q2
8 quarters
|
|
2
Microsoft
MSFT
$3.88T
| $238M | 1.69% |
5,398,740
+154,513
| +3% | +$7.05M |
2013 Q2
8 quarters
|
|
3
ExxonMobil
XOM
$770B
| $211M | 1.49% |
2,530,777
+2,011
| +0.1% | +$173K |
2013 Q2
8 quarters
|
|
|
4
UBS Group
UBS
$145B
| $191M | 1.35% |
8,952,559
+880,653
| +11% | +$18.4M |
2014 Q4
2 quarters
|
|
5
JPMorgan Chase
JPM
$895B
| $191M | 1.35% |
2,811,928
-59,604
| -2% | -$3.89M |
2013 Q2
8 quarters
|
|
6
Alphabet (Google) Class C
GOOG
$3.42T
| $186M | 1.31% |
6,997,660
-345,205
| -5% | -$9.25M |
2013 Q2
8 quarters
|
|
7
Wells Fargo
WFC
$250B
| $176M | 1.25% |
3,131,944
-63,755
| -2% | -$3.55M |
2013 Q2
8 quarters
|
|
8
Johnson & Johnson
JNJ
$658B
| $171M | 1.21% |
1,756,953
-74,495
| -4% | -$7.46M |
2013 Q2
8 quarters
|
|
|
9
GE Aerospace
GE
$313B
| $169M | 1.19% |
1,324,609
-141,715
| -10% | -$18.4M |
2013 Q2
8 quarters
|
|
10
Pfizer
PFE
$174B
| $161M | 1.14% |
5,051,157
-128,771
| -2% | -$4.2M |
2013 Q2
8 quarters
|
|
11
AT&T
T
$144B
| $141M | 1% |
5,246,023
-151,651
| -3% | -$3.92M |
2013 Q2
8 quarters
|
|
12
Procter & Gamble
PG
$374B
| $131M | 0.93% |
1,677,002
-24,098
| -1% | -$1.94M |
2013 Q2
8 quarters
|
|
13
Home Depot
HD
$328B
| $127M | 0.9% |
1,138,524
+61,147
| +6% | +$6.85M |
2013 Q2
8 quarters
|
|
14
Gilead Sciences
GILD
$212B
| $127M | 0.89% |
1,080,500
-63,967
| -6% | -$6.99M |
2013 Q2
8 quarters
|
|
15
Walt Disney
DIS
$192B
| $114M | 0.81% |
1,000,399
-13,244
| -1% | -$1.45M |
2013 Q2
8 quarters
|
|
16
Verizon
VZ
$185B
| $114M | 0.81% |
2,442,537
-60,911
| -2% | -$2.98M |
2013 Q2
8 quarters
|
|
17
Chevron
CVX
$462B
| $113M | 0.8% |
1,168,091
+1,956
| +0.2% | +$205K |
2013 Q2
8 quarters
|
|
18
Cisco
CSCO
$412B
| $111M | 0.78% |
4,036,567
+272,116
| +7% | +$7.8M |
2013 Q2
8 quarters
|
|
19
Amgen
AMGN
$252B
| $110M | 0.78% |
718,279
-45,337
| -6% | -$7.26M |
2013 Q2
8 quarters
|
|
20
Bank of America
BAC
$346B
| $109M | 0.77% |
6,423,263
-711,810
| -10% | -$11.7M |
2013 Q2
8 quarters
|
|
21
Boeing
BA
$136B
| $107M | 0.76% |
769,794
+14,251
| +2% | +$2.08M |
2013 Q2
8 quarters
|
|
22
Citigroup
C
$203B
| $104M | 0.73% |
1,879,629
-193,569
| -9% | -$10.5M |
2013 Q2
8 quarters
|
|
23
Meta Platforms (Facebook)
META
$1.6T
| $104M | 0.73% |
1,208,200
+72,394
| +6% | +$5.91M |
2013 Q2
8 quarters
|
|
24
Coca-Cola
KO
$405B
| $102M | 0.72% |
2,609,124
-61,506
| -2% | -$2.5M |
2013 Q2
8 quarters
|
|
25
Merck
MRK
$369B
| $102M | 0.72% |
1,875,140
-122,934
| -6% | -$6.89M |
2013 Q2
8 quarters
|
|
Similar funds
Aviva's Q2 2015 Portfolio in Review
As of Q2 2015, Aviva held 832 positions worth $14.1B, down 3.3% from $14.6B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Aviva withdrew a net $1.05B in Q2 2015, closing 15 positions and reducing 555 holdings. Its most notable exit was ACTAVIS PLC Pfd Conv Ser A (Irl), an estimated $14.4M position sold in full.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Aviva opened a new position in Allergan plc worth $16.7M.
- Aviva's largest Q2 2015 buy was Allergan plc: 16,000 shares worth $16.7M.
- Aviva added most to Union Pacific in Q2 2015, an estimated $24.2M increase.
- Aviva's biggest Q2 2015 reduction was Qualcomm, cutting an estimated $43.2M.
- Aviva fully exited ACTAVIS PLC Pfd Conv Ser A (Irl) in Q2 2015, selling an estimated $14.4M.
- Aviva's ten largest holdings make up 16% of its $14.1B portfolio in Q2 2015.
- Aviva opened 7 new positions and closed 15 in Q2 2015.
- Aviva's portfolio value fell 3.3% quarter-over-quarter to $14.1B.
Based on Aviva's 13F filing for Q2 2015, filed 6 Aug 2015.